市場調查報告書
商品編碼
1460167
肘部置換市場- 按產品(部分、全部、修訂)、材料(不銹鋼、鈷鉻合金、鈦合金)、適應症(骨關節炎、類風濕性關節炎、骨折)、最終用途(醫院、ASC)-全球預測、 2024 - 2032Elbow Replacement Market - By Product (Partial, Total, Revision), Material (Stainless Steel, Cobalt-Chromium Alloys, Titanium Alloys), Indication (Osteoarthritis, Rheumatoid Arthritis, Fracture), End-use (Hospital, ASC) - Global Forecast, 2024 - 2032 |
由於對微創手術 (MIS) 技術的需求不斷增加,2024 年至 2032 年肘關節置換市場規模預計將以 7.4% 的複合CAGR擴大。
最近,患者尋求更短的恢復時間和減少術後疼痛,進一步促使轉向微創肘關節置換手術。 MIS 切口更小、組織創傷更少、康復速度更快,吸引了更多人選擇肘關節修復。此外,新公司正在向未開發的地區擴張,多家公司正在進軍新興市場,為以前服務不足的地區帶來先進的肘部置換技術,進一步加速行業擴張到2032 年。例如,2023 年9 月, Linnaeus 旗下的Wear Referrals 在達勒姆郡成為英國第一個提供來自美國的革命性犬肘置換裝置的地方
彎頭更換產業分為產品、材料類型、適應症、最終用途和地區。
根據產品,修正彎頭更換細分市場的市場規模預計在 2024 年至 2032 年期間將以 6.8% 的成長率成長。修正肘關節置換手術涉及用新的肘關節替換先前植入的義肢肘關節,這通常是由於初次手術引起的磨損、鬆動和併發症。隨著人口老化和肘關節衰竭病例的增加,翻修手術的需求不斷增加。此外,植入材料、手術技術和假體設計的進步有助於專門解決修復手術的複雜性,以改善結果和患者滿意度,從而推動該細分市場的成長。
就最終用途而言,預計到 2032 年,骨科診所的肘關節置換市場複合CAGR將達到 7.8%。骨科診所是診斷、治療和管理肘關節疾病和損傷的重要中心。隨著患者對關節炎、骨折和退化性關節疾病的專業護理的偏好不斷增加,對肘關節置換手術的需求也增加。這些診所還提供全面的服務,包括術前評估、術後護理和康復,以滿足肘關節置換患者的特定需求。此外,手術技術、植入物設計和患者特異性治療的進步提高了骨科診所手術的效率和成功率,進一步推動了產品需求。
從地區來看,2024 年至 2032 年亞太地區彎頭置換產業的複合CAGR將達到 8.3%。老年人口的不斷增加導致該地區關節炎等疾病的高發生率。醫療服務的普及和持續的研發計劃正在推動肘關節置換手術的需求不斷成長。例如,2024 年 2 月,全印度醫學科學研究所與印度理工學院合作宣布,計劃很快開始對印度患者進行肘部置換手術的本土植入物進行臨床試驗。
此外,隨著人們對關節健康的認知不斷提高,中國、印度和日本等國家的骨科手術(包括肘關節置換術)數量激增。醫療技術的強勁進步、手術技術的改進以及熟練醫療保健專業人員的存在將促進區域產業的擴張。
Elbow Replacement Market size is set to expand at 7.4% CAGR from 2024 to 2032 owing to the increasing demand for minimally invasive surgery (MIS) techniques.
Of late, patients are seeking shorter recovery times and reduced post-operative pain, further prompting the shift towards less invasive elbow replacement procedures. MIS offers smaller incisions, decreased tissue trauma, and quicker rehabilitation, attracting more individuals to opt for elbow joint restoration. Additionally, new firms are expanding into untapped regions, and multiple companies are venturing into emerging markets for bringing advanced elbow replacement technologies to previously underserved areas, further accelerating the industry expansion through 2032. For instance, in September 2023, Linnaeus-owned Wear Referrals in County Durham emerged as the first in the U.K. to provide a revolutionary canine elbow replacement device from the U.S.
The elbow replacement industry is segmented into product, material type, indication, end-use, and region.
Based on product, the market size from the revision elbow replacement segment is projected to depict 6.8% growth rate from 2024-2032. Revision elbow replacement procedures involve replacing a previously implanted prosthetic elbow joint with a new one, often due to wear, loosening, and complications from the initial surgery. With an aging population and increasing cases of elbow joint failures, the demand for revision surgeries is rising. Moreover, advancements in implant materials, surgical techniques, and prosthetic designs help cater specifically to the complexities of revision procedures for improving outcomes and patient satisfaction, thereby propelling the segment growth.
In terms of end-use, the elbow replacement market from the orthopedic clinics segment is anticipated to attain 7.8% CAGR through 2032. Orthopedic clinics serve as crucial hubs for diagnosing, treating, and managing elbow joint conditions and injuries. With the increasing patient preference for specialized care for arthritis, fractures, and degenerative joint diseases, the demand for elbow replacement surgeries is increasing. These clinics also offer comprehensive services, including pre-surgical evaluations, post-operative care, and rehabilitation for catering to the specific needs of elbow replacement patients. Moreover, advancements in surgical techniques, implant designs, and patient-specific treatments enhance the efficiency and success rates of procedures performed in orthopedic clinics, further boosting the product demand.
Regionally, the Asia Pacific elbow replacement industry is set to exhibit 8.3% CAGR from 2024-2032. The presence of an expanding geriatric population is resulting in a high prevalence of conditions, such as arthritis in the region. The expanding access to healthcare services and the ongoing R&D initiatives are contributing to the growing demand for elbow replacement surgeries. For instance, in February 2024, the All India Institute of Medical Sciences, in partnership with IIT, announced plans to begin clinical trials of indigenous implants for elbow replacement procedures for Indian patients very soon.
Furthermore, countries like China, India, and Japan are witnessing a surge in orthopedic procedures, including elbow replacements, as awareness about joint health is rising. Strong advancements in medical technology, improved surgical techniques, and the presence of skilled healthcare professionals will bolster the regional industry expansion.